
Optieum and Genezen partner on LVV production for glioblastoma therapy
Viral vector contract development and manufacturing organization (CDMO) Genezen has jointly announced a partnership with Japanese biotech firm Optieum Biotechnologies to collaborate on GMP manufacturing for a lentiviral vector (LVV) construct used to …